MA26883A1 - Composition pharmaceutique. - Google Patents

Composition pharmaceutique.

Info

Publication number
MA26883A1
MA26883A1 MA26811A MA26811A MA26883A1 MA 26883 A1 MA26883 A1 MA 26883A1 MA 26811 A MA26811 A MA 26811A MA 26811 A MA26811 A MA 26811A MA 26883 A1 MA26883 A1 MA 26883A1
Authority
MA
Morocco
Prior art keywords
membrane
nail
forming
solvent
solution
Prior art date
Application number
MA26811A
Other languages
English (en)
Inventor
Robert Gyurik
Original Assignee
Bentley Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bentley Pharmaceuticals Inc filed Critical Bentley Pharmaceuticals Inc
Publication of MA26883A1 publication Critical patent/MA26883A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA26811A 2000-02-16 2002-09-11 Composition pharmaceutique. MA26883A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18292400P 2000-02-16 2000-02-16

Publications (1)

Publication Number Publication Date
MA26883A1 true MA26883A1 (fr) 2004-12-20

Family

ID=22670647

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26811A MA26883A1 (fr) 2000-02-16 2002-09-11 Composition pharmaceutique.

Country Status (17)

Country Link
EP (1) EP1257248B1 (fr)
JP (1) JP2005503318A (fr)
KR (2) KR20030016227A (fr)
CN (1) CN1422142A (fr)
AT (1) ATE526917T1 (fr)
AU (2) AU4318901A (fr)
BR (1) BR0108438A (fr)
CA (1) CA2400178A1 (fr)
HU (1) HUP0204555A3 (fr)
MA (1) MA26883A1 (fr)
MX (1) MXPA02008072A (fr)
NO (1) NO20023866L (fr)
NZ (1) NZ520749A (fr)
PL (1) PL357111A1 (fr)
TW (1) TWI232756B (fr)
WO (1) WO2001060325A1 (fr)
ZA (1) ZA200206553B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
GB0203276D0 (en) * 2002-02-12 2002-03-27 Novartis Ag Organic compounds
EP1545619B1 (fr) 2002-09-05 2008-01-23 Galderma S.A. Solution destinee a une application sur les ongles
JP4540667B2 (ja) 2003-03-21 2010-09-08 ネクスメツド・ホールデイングス・インコーポレイテツド 抗真菌性ネイルコート
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
JP5010125B2 (ja) * 2005-09-02 2012-08-29 有限会社日本健康科学研究センター 水虫治療用フィルム製剤
WO2007056068A2 (fr) * 2005-11-02 2007-05-18 Bentley Pharmaceuticals, Inc. Formulations macrocycliques pour l'administration transmembranaire de medicament
CA2633489C (fr) * 2005-12-14 2013-09-24 Zars Pharma, Inc. Compositions et procedes pour le traitement de conditions dermatologiques
JP5290582B2 (ja) * 2005-12-28 2013-09-18 帝國製薬株式会社 爪用医薬組成物
JP5502494B2 (ja) 2007-01-22 2014-05-28 ターガセプト・インコーポレイテッド メタニコチンアナログの鼻腔内、バッカル、または舌下投与
EP2745692A1 (fr) * 2009-02-13 2014-06-25 Topica Pharmaceuticals, Inc Formulation antifongique contenant du luliconalzole
AU2010226476B2 (en) * 2009-03-20 2013-02-07 Stiefel Laboratories, Inc. Fatty acid monoglyceride compositions
GB201021386D0 (en) * 2010-12-16 2011-01-26 Burke Michael H A process for the manufacture of an antifungal nail lacquer
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
KR101580077B1 (ko) * 2015-03-28 2015-12-24 한국콜마주식회사 시크로피록스 함유 네일락카 조성물
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (fr) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Composition pharmaceutique d'hormone steroide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US5731303A (en) * 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
DE3720147A1 (de) 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
EP0503312B1 (fr) * 1991-03-13 1997-01-08 Firmenich Sa Procédé de préparation de la 15-pentadécanolide ou de mélanges riches en cette macrolide
CA2211004A1 (fr) * 1994-10-20 1996-05-02 The Procter & Gamble Company Compositions de soins personnels et/ou compositions cosmetiques contenant un parfum persistant
US5693828A (en) * 1996-05-09 1997-12-02 International Flavors & Fragrances Inc. Process for preparing lactones and intermediates therefor
PT983037E (pt) * 1998-02-09 2003-09-30 Macrochem Corp Verniz para unhas antifungico
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
US6495124B1 (en) * 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same

Also Published As

Publication number Publication date
NZ520749A (en) 2004-06-25
HUP0204555A2 (en) 2003-05-28
PL357111A1 (en) 2004-07-12
EP1257248B1 (fr) 2011-10-05
AU2001243189B2 (en) 2005-06-09
NO20023866L (no) 2002-10-01
WO2001060325A1 (fr) 2001-08-23
ZA200206553B (en) 2003-11-17
AU4318901A (en) 2001-08-27
HUP0204555A3 (en) 2004-06-28
CA2400178A1 (fr) 2001-08-23
NO20023866D0 (no) 2002-08-15
TWI232756B (en) 2005-05-21
EP1257248A4 (fr) 2007-10-03
ATE526917T1 (de) 2011-10-15
MXPA02008072A (es) 2004-04-05
JP2005503318A (ja) 2005-02-03
CN1422142A (zh) 2003-06-04
BR0108438A (pt) 2003-04-01
KR20030016227A (ko) 2003-02-26
KR20080049148A (ko) 2008-06-03
EP1257248A1 (fr) 2002-11-20

Similar Documents

Publication Publication Date Title
MA26883A1 (fr) Composition pharmaceutique.
PT743860E (pt) Preparacao de microcapsulas ocas
JP2005503318A5 (fr)
PT1150661E (pt) Produto para pulverizacao para aplicacao topica
DE69814885D1 (de) Verfahren zur herstellung von arzneiformen mit kontrollierter wirkstoffabgabe auf polymerbasis
CA2548897A1 (fr) Agents endoparasiticides a application topique
MXPA03005375A (es) Formulacion repelente de insectos que contiene solventes polares, que tiene baja viscosidad y de entrega mediante dispositivo piezoelectrico.
SG166105A1 (en) Antifungal composition
ATE549015T1 (de) Pharmazeutische wirkstoffhaltige formulierung mit überzug
BR0205329A (pt) Composição lìquida formadora de pelìcula
ES2194991T3 (es) Composiciones no acuosas conteniendo un compuesto haloalquinilo y un tampon para promover actividad biocida y para estabilizar las composiciones finales.
ES2111272T3 (es) Mezclas herbicidas.
DE69828615D1 (de) Verwendung von inhibitoren der komplementaktivierung zur herstellung eines medikaments zur inhibierung von nebenwirkungen von pharmazeutischen zusammensetzungen, die amphiphile träger oder wirkstoffträger moleküle enthalten
BR112021023276A2 (pt) Cartucho compreendendo nicotina e um solvente imiscível em água
JPS5598112A (en) Liquid medicine for external use
HUP0301886A2 (hu) Vivżanyag vegyi anyagok fára történż felvitelére, ilyet tartalmazó készítmény és alkalmazása
JP2002167301A (ja) 不快害虫用エアゾール組成物
KR910700066A (ko) 경피약제투여 조성물
AU9221898A (en) Pharmaceutical coating composition and method of use
CO4370014A1 (es) Soluciones inyectables estables de diritromicina
ES2156181T3 (es) Utilizacion de un disacarido como estabilizante de mezclas liquidas de proteinas y mezclas liquidas de proteinas que contienen un disacarido.
GT199600029A (es) Sal de pirrolidinil metil indol
ID26032A (id) Metode dan komposisi untuk menyetabilkan komposisi asetilkolin
WO2000023022A8 (fr) Procedes et compositions permettant de former in situ des films protecteurs et/ou comprenant des medicaments sur des tissus corporels
Yuningtyaswari THE EFFECT OF AIR FRESHENER EXPOSURE ON CORNEAL THICKNESS OF WHITE RAT (RATTUS NORVEGICUS)